Notably, higher body mass index (BMI) is associated with increased IBC risk (8), impacting both estrogen receptor (ER)-positive and ER-negative IBC cases in pre- and peri/postmenopausal women (9). The gene discussed is ESR1; the disease is inflammatory breast carcinoma.